IL-33 Effect on Quantitative Changes of CD4⁺CD25^highFOXP3⁺ Regulatory T Cells in Children with Type 1 Diabetes

Table 3

The status of CD4⁺CDFOXP3⁺ and CD4⁺CDFOXP3⁺ST2⁺ Treg cells after in vitro treatment with IL-33 in control group.

	CD4^+CDFOXP3^+ (%)	CD4^+CDFOXP3^+ST2^+ (%)	MFI of FOXP3 among CD4^+CDFOXP3^+ cells	MFI of ST2 among CD4^+CDFOXP3^+ cells
Nonstimulated	4.9 (3.7/6.8)	2.5 (1.4/3.0)	4.12 (1.4/7.3)	6.3 (1.6/8.22)
IL-33 stimulated	4.95 (4.0/6.0)	2.55 (0.6/3.6)	4.15 (1.2/5.2)	5.63 (0.99/8.0)
	0.57	0.75	0.34	0.22

MFI: Mean Fluorescence Intensity.
Differences were calculated with the nonparametric Wilcoxon test.
Data are presented as median and 10th/90th percentile.